Queensland Free Flu Vaccination Program to continue in 2027
On 13 November 2026, the Honourable Tim Nicholls, Minister for Health and Ambulance Services, announced the return of the Queensland Free Flu Vaccination Program in 2027.
The 2027 program will operate in similar way to the 2026 program and will again include the needle-free nasal spray influenza vaccine, FluMist. This announcement is intended to give stakeholders and immunisation providers sufficient time to prepare for the 2027 season.
Providers are encouraged to begin considering how they will:
- Operationalise and deliver the vaccination program
- Store the vaccine
- Identify eligible groups and promote the program
- Determine their ordering requirements for NIP-funded influenza and FluMist vaccines.
There is no set start date for the 2027 program. It will commence when 2027 influenza vaccine stock becomes available and will conclude on 30 September 2027.
The Minister’s media statement is available online.
Program eligibility for 2027
All Queenslanders aged 6 months and older will be eligible for a funded influenza vaccine.
FluMist will be funded for:
- all children aged 2–4 years (inclusive)
- children and adolescents aged 5–17 years (inclusive) who struggle with needles.
Key change for awareness
Please note that in 2027, there will be no subsidy as part of the Queensland Free Flu Vaccination Program for privately purchased non-standard* influenza vaccines. This change is intended to simplify the reimbursement model.
*the table on our website outlines the standard and non-standard vaccines on the market.
Further information
Further information will be provided as details become available, including:
- rollout arrangements
- vaccine supply and ordering, including for influenza vaccines available under the National Immunisation Program (NIP)
- detailed eligibility criteria
- reimbursement arrangements
- supporting resources and provider guidance.
-
16/11/26 | AnnouncementsNew interim RSV advice for Aboriginal and Torres Strait Islander children
Read More -
-